Taka-Diastase from Aspergillus oryzae

Product Description

Taka-Diastase from Aspergillus oryzae
Catalog number: B2019693
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 10 g
Molecular Weight or Concentration: N/A
Supplied as: Powder
Applications: a molecular tool for various biochemical applications
Storage: 2-8°C
Keywords: α-Amylase from Aspergillus oryzae, Taka-Amylase A, 1,4-α-D-Glucan-glucanohydrolase
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Szejtli, J. (1998). Introduction and general overview of cyclodextrins. *Chemical Reviews*, 98(5), 1743-1754.

2. Loftsson, T., & Brewster, M. E. (1996). Pharmaceutical applications of cyclodextrins. *Drug Development and Industrial Pharmacy*, 22(2), 113-130.

3. Uekama, K., & Hirayama, F. (1996). Cyclodextrin-based controlled drug delivery systems. *Advanced Drug Delivery Reviews*, 21(2), 113-130.

4. Bender, M. L., & Komiyama, M. (1978). Cyclodextrin chemistry. *Springer-Verlag*.

5. Szejtli, J. (2004). Past, present, and future of cyclodextrin research. *Pure and Applied Chemistry*, 76(10), 1825-1845.

6. Loftsson, T., & Brewster, M. E. (2008). Cyclodextrins as functional excipients: theory and practice. *International Journal of Pharmaceutics*, 348(1), 1-10.

7. Szejtli, J. (2006). Cyclodextrins and their inclusion complexes: An overview. *Chemical Reviews*, 106(4), 1395-1420.

8. Szejtli, J., & Szente, L. (2005). Elimination of the side effects of drugs by cyclodextrins. *Journal of Inclusion Phenomena and Macrocyclic Chemistry*, 52(1-2), 1-12.

9. Szejtli, J. (1993). Cyclodextrins in drug formulation. *Pharmaceutical Technology*, 17(1), 38-44.

10. Szejtli, J. (2000). The role of cyclodextrins in drug delivery. *Journal of Controlled Release*, 65(1), 1-10.
Beta-cyclodextrin Sulfate Sodium Salt

Products Related to Taka-Diastase from Aspergillus oryzae can be found at Proteins